Monsanto’s winning streak in Roundup trials ended Friday after a St. Louis jury awarded $1.25 million to the plaintiff.
Jurors found that Monsanto failed to warn about the risks that Roundup and its active ingredient, glyphosate, could cause non-Hodgkin lymphoma, which plaintiff John Durnell was diagnosed with at age 67. The jury, however, rejected claims that Monsanto was negligent in designing a defective product and declined to award punitive damages.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
